other Versions

PDF
Systematic review
Some evidence that continuous subcutaneous insulin infusion for type I diabetes improves glycaemic control compared with multiple daily injections, but few trials have compared CSII with MDI using newer insulin analogues

Share this article

Click the icon of the social media platform on which you would like to share this article.

Email this article to a friend

We will not keep your email address; we ask for it so your friend knows the email isn't spam.
Enter multiple addresses on separate lines or separate them with commas.
(Your Name) has forwarded a page to you from Evidence-Based Nursing
(Your Name) thought you would like to see this page from the Evidence-Based Nursing web site.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.